Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 29
Item hits:
Issue DateTitleAuthor(s)
1-Mar-2019Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleedingArachchillage, DRJ; Alavian, S; Griffin, J; Gurung, K; Szydlo, R, et al
1-Jun-2020Absence of JAK2V617F mutated endothelial colony-forming cells in patients with JAK2V617F myeloproliferative neoplasms and splanchnic vein thrombosisGuy, A; Danaee, A; Paschalaki, K; Boureau, L; Riviere, E, et al
17-Aug-2020Thrombolysis restores perfusion in COVID-19 hypoxiaArachchillage, DJ; Stacey, A; Akor, F; Scotz, M; Laffan, M
1-Oct-2020Red cell alloimmunisation in patients receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO)Arachchillage, DRJ; Owen, S; Anievas, M; Gaspar, M; Laffan, M
Sep-2020Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVIDÔÇÉ19Arachchillage, DJ; Remmington, C; Rosenberg, A; Xu, T; Passariello, M, et al
1-Nov-2019Use of Antithrombin concentrate for acquired antithrombin deficiency in acutely unwell children receiving unfractionated heparinJayakody Arachchillage, DR; Gaspar, M; Makhecha, S; Laffan, M
May-2020Frequency of thrombocytopenia and heparin induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared to cardiopulmonary bypass and the limited sensitivity of pre-test probability scoreJayakody Arachchillage, DR; Laffan, M; Khanna, S; Vandenbriele, C; Kamani, F, et al
1-Sep-2019Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patientsArachchillage, DRJ; Vipond, L; Laffan, M
1-Sep-2019Pathogenesis and management of thrombotic disease in myeloproliferative neoplasmsArachchillage, DR; Laffan, M
12-Jul-2020Platelet function in patients with chronic myeloid leukemia treated with asciminibNesr, G; Laffan, M; Claudiani, S; Innes, A; Apperley, J, et al